Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Primary Health Properties defends its Assura bid over Sana offer

(Sharecast News) - Primary Health Properties defended its £1.2bn offer for Assura on Friday, reiterating that the proposed all-share and cash deal offered strategic and financial benefits, as it urged Assura shareholders not to accept a rival bid from private equity-backed Sana Bidco. PHP said that its offer, based on its 12 June closing share price of 103p, valued Assura at 53p per share, representing a 1.7% premium to the Bidco offer.

In a statement responding to Assura's 11 June recommendation of the Bidco proposal, PHP said it would support a special dividend of up to 0.84p per share to accelerate Assura's October dividend, and said it had also aligned its offer acceptance threshold with Bidco's at 50% of voting rights.

The FTSE 250 company rejected Assura's claims regarding financial and execution risks associated with the merger, pointing to a planned deleveraging strategy, supportive credit ratings, and positive early interest from joint venture partners in the anticipated asset disposals.

It also highlighted Fitch's confirmation that Assura would retain an investment-grade rating post-merger and said refinancing needs were well covered under its £1.225bn financing arrangements.

On execution risks, PHP noted its successful 2019 merger with MedicX and argued that the two firms' portfolios and systems were complementary.

It also emphasised its track record of outperforming Assura on total property returns over one-, three-, five-, and seven-year periods.

PHP also pushed back against Assura's comments on integration complexity and reduced exposure to inflation-linked leases, claiming the combined portfolio would deliver greater income security via a £6 billion platform of primarily government-let assets.

Finally, PHP said it had initiated pre-notification dialogue with the Competition and Markets Authority (CMA) and accused Assura of delaying the process by withholding key documents.

It urged cooperation to avoid unnecessary regulatory delays and said it remained open to further engagement.

At 1147 BST, shares in Primary Health Properties were down 0.38% at 102.61p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.